Journal articleJ Control Release2026

MβCD@HA-Ad nanoparticles inhibit pancreatic cancer progression by targeting Caveolin-1/Piezo1/PLA2G4A-mediated lipid reprogramming.

DOI 10.1016/j.jconrel.2026.115223 ↗ OpenAlex, retrieved 5 November 2026

Journal: J Control Release
Published: 30 July 2026
Citations: 0
Type: Article

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try